CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 149 enrolled
Drug / intervention
Sculptra Aesthetic new dilutiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04124692
NCT04124692N/ACompleted

A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study to Evaluate the Effectiveness and Safety of Sculptra Aesthetic for Correction of Cheek Wrinkles.

Galderma R&D·interventional·Posted Oct 11, 2019·Updated Nov 18, 2023

In Brief

A clinical study evaluating Sculptra Aesthetic new dilution for Cheek Wrinkles. Completed, enrolled 149 participants across 13 sites.

Detailed Summary

The study has been designed to evaluate the safety and effectiveness of Sculptra Aesthetic as a single regimen for correction of cheek wrinkles after changes in reconstitution and injection procedures compared to the approved label.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCheek Wrinkles
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedOct 11, 2019
Enrollment StartNov 12, 2019
Primary CompletionAug 12, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.7 years ago

Interventions

Sculptra Aesthetic new dilutiondevice

Treatment of cheek wrinkles